Lundbeck Australia

By the 1990's Lundbeck’s International distribution and marketing contacts were well established around Europe, the UK, Canada and South Africa.

Lundbeck researched and identified an opportunity to enter the Australasian market and in January 1997 Lundbeck Australia was established by a handful of experienced and dedicated employees. It started as a trading company with two conventional antipsychotics Fluanxol (flupenthixol) and Clopixol (zuclopenthixol) as the sole products for marketing.

Lundbeck Australia strengthens the company's position as specialists in brain diseases.

It is part of the Lundbeck Australia philosophy that our role with the medical profession is one of education and support. For this reason from our establishment in 1997 we have ensured that our activities and resources are focused on providing information, educational books and meetings.

By providing educational and supportive platforms for both learning and teaching we aim to develop an understanding with treating physicians and care providers which helps us identify areas that require more focus, or future research.

Lundbeck Australia is committed to disclosing the financial &/or non-financial support we provide to Health Consumers Organisations:

- SANE Australia
- Parkinson's NSW
- Unity Walk & Fun Run
- Mental Health Council of Australia

You are now leaving lundbeck.com.au. Please note that the information contained in the site you are linking to may not be fully compliant with the Australian regulatory environment and that product related information should be checked against the corresponding Australian consumer medicine information or by asking your doctor. Any information provided should be discussed with your health care professional and does not replace the advice and treatment of your doctor. We hope you will visit us again soon.